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Objectives: Recently we deﬁned several independent
high-risk criteria that were inclusive and exclusive of the
SAPPHIRE (Stenting with Angioplasty and Protection in
Patients at High Risk for Endarterectomy) trial. The objec-
tive of this study was to create a risk index that may predict
patients at high risk for carotid endarterectomy (CEA).
Methods: Data on 3,098 CEAs between 2003 and
2011 at 20 Vascular Study Group of New England
(VSGNE) centers were used for this study. SAPPHIRE
general inclusion criteria and primary outcomes of death,
stroke, or myocardial infarction were used, as were other
previously reported high-risk criteria. Factors that were
associated with the primary outcome by analysis of variance
(P < .10) and not linearly dependent, as determined by a
Pearson’s correlation analysis, were further assessed for an
independent association by multivariate logistic regression.
A risk index model was developed for these signiﬁcant pre-
dictors using an integer score as a reliable formula.
Results: Multivariate analysis (P < .05) found the
following independently signiﬁcant risk factors (95% conﬁ-
dence interval): age in years (1.0-1.1; P < .001), preadmis-
sion nursing home (1.2-6.6; P ¼ .020), congestive heart
failure (CHF; 1.4-2.8; P < .001), diabetes (1.1-1.3; P <
.001), chronic obstructive pulmonary disease (COPD;
1.2-1.5; P < .001), any previous cerebrovascular disease
(CVD; 1.1-1.9; P ¼ .003), and contralateral internal ca-
rotid artery stenosis (1.0-1.2; P ¼ .001). The predictors
are age in years (40-49: 0 points; 50-59: 2 points; 60-69:
4 points; 70-79: 6 points; 80-89: 8 points), living in a
nursing home (4 points), any CVD (2 points), CHF (5
points), COPD (3 points), diabetes (2 points), degree of
contralateral stenosis (<50%: 0 points; 50-69%: 1 point;
70-near occlusion: 2 points; occlusion: 3 points). Lowest-
risk CEA was deﬁned as 0 points with an estimated risk
of 2.7%, highest-risk CEA was deﬁned as >13 points, rep-
resenting adverse outcome rate of 22.5%.
Conclusions: The SAPPHIRE high-risk CEA deﬁni-
tion is not accurate. We propose a new, evidence-baseddeﬁnition of high-risk CEA. The CEA risk index model
may assist clinicians in appropriate patient selection. Future
studies should aim at validation of this risk index model.
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Objectives: There is an ongoing debate regarding the
role of carotid interventions in asymptomatic patients, espe-
cially women. We sought to compare immediate and long-
termoutcomes in asymptomaticmenandwomenundergoing
carotid artery stenting (CAS) or carotid endarterectomy
(CEA).
Methods: We identiﬁed 27,531 hospitalizations of
asymptomatic patients with CEA or CAS among 2005-
2009 California discharges by International Classiﬁcation
of Diseases, Ninth Revision-Clinical Modiﬁcation codes.
Baseline characteristics were compared, and propensity
scores were calculated with a logistic regression model
that adjusted for clinical differences. Thirty-day mortality
and adverse neurologic event rates as well as 4-year survival
and ischemic stroke rates were analyzed in populations
matched by gender and procedure.
Results: There were 10,399 women and 13,765 men
with CEA and 1,421 women and 1,946 men with CAS. In
unmatched populations, CAS compared with CEA was
associated with more 30-day neurologic events for both
women (3.3% vs 2.4%; P ¼ .012) and men (4.1%
vs 2.9%; P ¼ .011). This difference persisted in matched
populations. There was no difference in 30-day mortality
with or without matching. When compared with CEA
during 4 years of follow-up, unmatched patients after
CAS had inferior overall survival irrespective of whether
they were female (79.3% vs 82.8%; P ¼ .006) or male
(74.7% vs 80.5%; P < .001). Men compared with women
experienced worse survival after CAS (P ¼ .006) or CEA
(P < .001). However, after CEA, women at 4 years had
higher ischemic stroke rates than men (4.6% vs 3.3%; P
< .001) but similar rates of ischemic strokes after CAS.
These gender differences persisted in matched popula-
tions. After matching, CEA vs CAS patients experienced
fewer ischemic strokes among men (3.6% vs 4.4%; P ¼
.044), but not among women.
Conclusions: CAS compared with CEA patients had
worse long-term survival in both genders and more
ischemic strokes in men. Women had better survival
regardless of procedure, whereas men with CEA had less
ischemic strokes over 4 years. These results should be taken
into account during counseling for carotid intervention.
